Enhancing cost-effectiveness considerations in the adoption of new drugs in Hong Kong | HKMJ
Hong Kong Med J 2025 Aug;31(4):312–5 | Epub 23 Jul 2025 https://doi.org/10.12809/hkmj2412259 © Hong Kong Academy of Medicine.
Related Articles
Finding the Right Match: Who Should Opt for Anti–CTLA-4 and Programmed Cell Death Protein-1 Combination Therapy?
The emergence of immune checkpoint inhibitors (ICIs) has profoundly changed the landscape of cancer treatment. These agents have revolutionized the way we approach various malignancies,…
Retrospective Data Highlight Improved Efficacy With Maintenance Therapy vs Treatment Breaks in mCRC: With Connie Lai, MD
Podcast 單集 · OncLive® On Air · 31/07/2025 · 5 分鐘
精靈一點：軟組織肉瘤
#精靈一點 #軟組織肉瘤 #腫瘤1300-1400主題：軟組織肉瘤嘉賓：龍浩鋒醫生(香港中文大學醫學院腫瘤學系臨床副教授)1400-1500主題：三高自行停藥風險嘉賓：曾子欣醫生(心臟科專科醫生)
Dr Loong on Sevabertinib in HER2-Mutant NSCLC: SOHO-01 Trial Insights
Sevabertinib shows promise as a targeted therapy for HER2-mutant non-small cell lung cancer, addressing significant treatment gaps in this area.
Dr Loong on Sevabertinib in HER2-Mutant NSCLC: SOHO-01 Trial Insights
Sevabertinib shows promise as a targeted therapy for HER2-mutant non-small cell lung cancer, addressing significant treatment gaps in this area.
Welcome! You are invited to join a webinar: Updates from ASCO. After registering, you will receive a confirmation email about joining the webinar.
ASCO (American Society of Clinical Oncology) is an important conference in the oncology community where new scientific research updates are shared. The Life Raft Group…
CTOS: Connective Tissue Oncology Society (@ctosociety) • Instagram reel
3 likes, 0 comments – ctosociety on May 14, 2025: “CTOS President Silvia Stacchiotti inviting everyone to join CTOS annual meeting in Boca Raton to…
Jasmine Kamboj: POLICY webinar with the experts and leaders in advocacy and policy – OncoDaily
Jasmine Kamboj: POLICY webinar with the experts and leaders in advocacy and policy / cancer, fight against cancer, Global fight against cancer, Jasmine
Oncology Trialists and Their Minions – ILCN.org (ILCN/WCLC)
Poet and ILCN Editor-in-Chief Corey Langer, MD, illustrates the build-up and anticipation surrounding the release of research data.